As drug demand surged during the early months of the pandemic, the US Food and Drug Administration (FDA) published temporary guidelines to free up a pharmaceutical drug source that seemed much more domestic: drug compounders, or specific pharmacies and outsourcing facilities that make specialized drug formulations.So to what extent can drug compounding help with shortages?
Or, is the very question indicative of a bigger problem?Stephen W. Schondelmeyer, PharmD, PhD, co-principal of the Resilient Drug Supply Project at the University of Minnesota's Center for Infectious Disease Research and Policy, publisher of CIDRAP News, says drug compounders can be an important Band-Aid, but they are little more than a short-term solution."503Bs won't